USFDA inspects Divis Laboratories’ Unit-II at Andhra Pradesh

07 Jun 2014 Evaluate

Divis Laboratories has undergone an inspection by the USFDA, with no major observations, for its Unit-II at Chippada village, Bheemunipatnam Mandal, near Visakhapatnam in state of Andhra Pradesh during June, 2014. The audit concluded with one observation primarily about further improvement of existing procedure. The purpose of this inspection was for Custom manufactured product.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

6341.90 -47.40 (-0.74%)
30-Dec-2025 11:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.70
Dr. Reddys Lab 1267.50
Cipla 1488.00
Zydus Lifesciences 901.10
Lupin 2078.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×